Kardigan, Inc. (KARD)
NASDAQ · Manufacturing · Pharmaceutical preparations
$14.83+$0.4400 (+3.06%) on the dayAs of the close; data may be delayed.
KARD price, last 12 months
Key stats
- Previous close
- $14.39
- Open
- $14.50
- Day range
- $14.07 – $15.60
- 52-week range
- $13.75 – $27.00
- Volume
- 482.6K
- Avg volume (20 days)
- 805.7K
- Market cap
- $1.4B
Performance
1W−10.9%
1M−30.0%
3M−37.2%
6M—
YTD—
1Y—
Technicals and fundamentals
About Kardigan, Inc.
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.4B